160 related articles for article (PubMed ID: 24214603)
1. Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.
Wang S; Chen Y; Liu X; Xu X; Liu X; Liu BF; Zhang G
Arch Pharm (Weinheim); 2014 Jan; 347(1):32-41. PubMed ID: 24214603
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a series of benzoxazole/benzothiazole-containing 2,3-dihydrobenzo[b][1,4]dioxine derivatives as potential antidepressants.
Wang S; Chen Y; Zhao S; Xu X; Liu X; Liu BF; Zhang G
Bioorg Med Chem Lett; 2014 Apr; 24(7):1766-70. PubMed ID: 24618300
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antidepressant activity of a series of arylalkanol and aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Xiao Y; Zhang QW; Li JQ
Bioorg Med Chem Lett; 2017 Dec; 27(24):5420-5423. PubMed ID: 29138029
[TBL] [Abstract][Full Text] [Related]
5. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
6. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist.
Chen HX; Jin ZL; Zhang LM; Xue R; Xu XD; Zhao N; Qiu ZK; Wang XW; Zhang YZ; Yang RF; Li YF
PLoS One; 2013; 8(12):e83271. PubMed ID: 24367588
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
9. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
Qin JJ; Chen HX; Zhao N; Yuan L; Zhang YZ; Yang RF; Zhang LM; Li YF
Neurosci Lett; 2014 Oct; 582():104-8. PubMed ID: 25220701
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT
Yuan RX; Jiang KY; Wu JW; Zhang ZX; Li MS; Li JQ; Ni F
Bioorg Med Chem Lett; 2022 Nov; 76():129006. PubMed ID: 36202190
[TBL] [Abstract][Full Text] [Related]
11. Discovery of SMP-304, a novel benzylpiperidine derivative with serotonin transporter inhibitory activity and 5-HT
Yoshinaga H; Masumoto S; Koyama K; Kinomura N; Matsumoto Y; Kato T; Baba S; Matsumoto K; Horisawa T; Oki H; Yabuuchi K; Kodo T
Bioorg Med Chem; 2017 Jan; 25(1):293-304. PubMed ID: 27865645
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect.
Wróbel MZ; Chodkowski A; Herold F; Marciniak M; Dawidowski M; Siwek A; Starowicz G; Stachowicz K; Szewczyk B; Nowak G; Belka M; Bączek T; Satała G; Bojarski AJ; Turło J
Eur J Med Chem; 2019 Dec; 183():111736. PubMed ID: 31586817
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity.
Hatzenbuhler NT; Evrard DA; Harrison BL; Huryn D; Inghrim J; Kraml C; Mattes JF; Mewshaw RE; Zhou D; Hornby G; Lin Q; Smith DL; Sullivan KM; Schechter LE; Beyer CE; Andree TH
J Med Chem; 2006 Jul; 49(15):4785-9. PubMed ID: 16854086
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists.
Partyka A; Zagórska A; Kotańska M; Walczak M; Jastrzębska-Więsek M; Knutelska J; Bednarski M; Głuch-Lutwin M; Mordyl B; Janiszewska P; Wesołowska A
PLoS One; 2020; 15(8):e0237196. PubMed ID: 32764777
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism.
Oficialdegui AM; Martinez J; Pérez S; Heras B; Irurzun M; Palop JA; Tordera R; Lasheras B; del Río J; Monge A
Farmaco; 2000 May; 55(5):345-53. PubMed ID: 10983279
[TBL] [Abstract][Full Text] [Related]
20. Discovery of DSP-1053, a novel benzylpiperidine derivative with potent serotonin transporter inhibitory activity and partial 5-HT
Yoshinaga H; Nishida T; Sasaki I; Kato T; Oki H; Yabuuchi K; Toyoda T
Bioorg Med Chem; 2018 May; 26(8):1614-1627. PubMed ID: 29456112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]